Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.
about
Laryngeal and vocal evaluation in untreated growth hormone deficient adultsAdipokine profile and urinary albumin excretion in isolated growth hormone deficiencyGrowth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor geneRelationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults.The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance.Brazilian adult individuals with untreated isolated GH deficiency do not have accelerated subclinical atherosclerosis.Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor geneGrowth hormone status predicts left ventricular mass in patients after cure of acromegaly.Climacteric in untreated isolated growth hormone deficiency.Blood pressure in pediatric patients with Cushing syndrome.Lipid effects of endocrine medications.Older individuals heterozygous for a growth hormone-releasing hormone receptor gene mutation are shorter than normal subjects.Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.Liver status in congenital, untreated, isolated GH deficiency.The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency.Isolated growth hormone deficiency due to the R183H mutation in GH1: Clinical analysis of a four-generation family.
P2860
Q30490299-F5BF9379-D3A8-49E0-B8C2-21C2E1C671BFQ33736161-7B254EC4-E8EF-4A2A-A0E9-1A7D203B30C1Q33736166-5F609EF5-3D48-4C37-9155-8282992B0CB2Q33736206-3E2AF957-ADA5-4090-9258-7913863DC157Q33926905-4EA7378B-9FCA-4D54-8FE1-CD69805AE88FQ35737624-3EF7E10A-C70C-4B3D-BCEA-142907EFE677Q36536001-81782E75-08F1-4826-830F-01B19F827233Q36807284-B29475CF-8DD0-494F-9F5F-CB3290AEA3D8Q36896880-7687429B-DABF-4C69-AD26-5AA24E572CA0Q36953916-A4CB07AC-E795-4712-A054-287999D565C7Q37212316-473FAAE6-CADD-4641-AA16-F836DEEE1FF5Q37811982-4D340590-66DB-49DC-A244-14F1ED001B2AQ41243858-0A5256F9-BC9D-4E74-B789-3184649E3CE3Q41776005-31CF1868-18C9-4D17-9423-BDDEA24D0AD7Q41936028-E2302FF8-7918-40DC-840E-FB534C59AE85Q44818645-2A79E3EB-035D-4616-9CAB-D8282CD5D819Q48150293-C985903E-C543-456A-9EEC-D1E92AB5558EQ48260309-06A161F3-826C-40B3-B9D1-D556359482C8
P2860
Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@en
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@nl
type
label
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@en
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@nl
prefLabel
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@en
Familial isolated growth hormo ...... ral obesity, and dyslipidemia.
@nl
P2093
P921
P356
P1476
Familial isolated growth hormo ...... tral obesity, and dyslipidemia
@en
P2093
Anita Hermínia Souza
José Augusto Soares Barreto-Filho
Manuel Hermínio Aguiar-Oliveira
Marta Regina S Alcântara
Martha Azevedo Barreto
Matthew S Gill
Roberto Salvatori
Rossana Maria C Pereira
Valquíria Bastos
P304
P356
10.1210/JC.87.5.2018
P407
P577
2002-05-01T00:00:00Z